IGC
Price:
$0.3061
Market Cap:
$26.04M
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Industry
Biotechnology
IPO Date
2006-05-24
Stock Exchange
AMEX
Ticker
IGC
According to IGC Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -96.36%. This represents a change of 297.58% compared to the average of -24.24% of the last 4 quarters.
The mean historical ROE of IGC Pharma, Inc. over the last ten years is -56.80%. The current -96.36% ROE has changed 69.64% with respect to the historical average. Over the past ten years (40 quarters), IGC's ROE was at its highest in in the December 2016 quarter at -1.48%. The ROE was at its lowest in in the December 2023 quarter at -61.74%.
Average
-56.80%
Median
-28.69%
Minimum
-177.57%
Maximum
-12.20%
Discovering the peaks and valleys of IGC Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 150.03%
Maximum Annual ROE = -12.20%
Minimum Annual Increase = -44.89%
Minimum Annual ROE = -177.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | -112.50% | -36.65% |
| 2024 | -177.57% | 130.12% |
| 2023 | -77.16% | 22.78% |
| 2022 | -62.85% | 133.99% |
| 2021 | -26.86% | -11.97% |
| 2020 | -30.51% | 150.03% |
| 2019 | -12.20% | -44.89% |
| 2018 | -22.15% | -12.71% |
| 2017 | -25.37% | 21.75% |
| 2016 | -20.84% | -35.72% |
The current ROE of IGC Pharma, Inc. (IGC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-122.41%
5-year avg
-91.39%
10-year avg
-56.80%
IGC Pharma, Inc.’s ROE is greater than Nutriband Inc. (-131.40%), greater than AN2 Therapeutics, Inc. (-47.97%), greater than Boundless Bio, Inc. (-44.79%), less than Plus Therapeutics, Inc. (335.91%), less than Q32 Bio Inc. (580.22%), less than Pluri Inc. (468.40%), less than Iterum Therapeutics plc (602.38%), less than SAB Biotherapeutics, Inc. (33.39%), greater than NextCure, Inc. (-107.57%), greater than Intensity Therapeutics, Inc. (-370.86%),
| Company | ROE | Market cap |
|---|---|---|
| -131.40% | $56.47M | |
| -47.97% | $29.18M | |
| -44.79% | $24.62M | |
| 335.91% | $39.62M | |
| 580.22% | $44.54M | |
| 468.40% | $23.49M | |
| 602.38% | $21.14M | |
| 33.39% | $36.32M | |
| -107.57% | $34.11M | |
| -370.86% | $21.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGC Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IGC Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is IGC Pharma, Inc.'s ROE?
How is the ROE calculated for IGC Pharma, Inc. (IGC)?
What is the highest ROE for IGC Pharma, Inc. (IGC)?
What is the 3-year average ROE for IGC Pharma, Inc. (IGC)?
What is the 5-year average ROE for IGC Pharma, Inc. (IGC)?
How does the current ROE for IGC Pharma, Inc. (IGC) compare to its historical average?